The Rapid Response® Influenza AB COVID-19 Antigen Test is a rapid, lateral flow immunoassay for the detection and differentiation of nucleoprotein antigens from SARS-CoV-2, Influenza A and Influenza B in individuals suspected of COVID-19 or Influenza A or B within the first 7 days of symptoms onset. The test is intended for use by healthcare professionals and laboratory personnel trained to perform the test. The Rapid Response® Influenza AB COVID-19 Antigen – 3 in 1 Test is authorized under the Health Canada Interim Order (IO #356389). This test is suitable for use by healthcare professionals and laboratory personnel trained to perform the test. Omicron Variant Update: Click Here to read our latest update on the impact of the Omicron variant of SARS-CoV-2 on the Rapid Response® Influenza AB COVID-19 Antigen Test.
